← All trials
Cellular SenescenceRecruiting
Senolytic Combination Therapy in Early Frailty
Phase II study of combination senolytic therapy in adults with early markers of frailty and elevated cellular senescence burden.
Sponsor
Mayo Clinic Center for Regenerative Medicine (Rochester, United States)
Lead investigator
Marcus Alvarez, MD
Leads early-phase senolytic and senomorphic trials targeting frailty and cellular senescence.
Trial sites
- Mayo Clinic Center for Regenerative Medicine (Rochester, United States)
- Karolinska Longevity Institute (Stockholm, Sweden)